The global Erectile Dysfunction Treatment Market can be segmented based on type of treatment, distribution channel, and geography. Based on type of treatment, the market can be classified into phosphodiesterase type 5 (PDE5) inhibitors, prostaglandin E1 (PGE1) agonists, testosterone replacement therapy, and others. PDE5 inhibitors are the most commonly prescribed treatment for ED, accounting for more than 80% of the market share in 2020. Tadalafil is the most popular PDE5 inhibitor, with sales of more than $1.5 billion in 2020. Based on distribution channel, the market can be classified into hospital pharmacies, retail pharmacies, and online pharmacies. Retail pharmacies are the largest distribution channel for ED treatment, accounting for more than 50% of the market share in 2020. However, online pharmacies are expected to grow at a faster rate, driven by the convenience of home delivery and the availability of discounts and offers.
In recent years, several new drugs have been approved for the treatment of ED, including avanafil, tadalafil, and vardenafil. These drugs work by increasing blood flow to the penis, making it easier for men to achieve and maintain an erection. In addition, there are also non-pharmacological treatment options, such as vacuum erection devices, penile implants, and psychotherapy, which are gaining popularity among patients.
The global market for ED treatment was valued at $4.39 billion in 2020 and is expected to reach $6.63 billion by 2028, growing at a CAGR of 5.2% from 2021 to 2028. North America is the largest market for ED treatment, accounting for more than 40% of the global market share in 2020. Europe and Asia-Pacific are also significant markets, with growing demand for ED treatment in countries such as China, Japan, and India.
Read more @ https://creativeedge16.blogspot.com/2023/03/global-erectile-dysfunction-treatment.html
